Efficacy of rimonabant in obese patients with binge eating disorder

Pataky, Zoltan; Gasteyger, Curt; Ziegler, O.; Rissanen, A.; Hanotin, C.; Golay, Alain

doi:10.1055/s-0032-1329957

Scientific article

English

Efficacy of rimonabant in obese patients with binge eating disorder

ContributorsPataky, Zoltan

; Gasteyger, Curt; Ziegler, O.; Rissanen, A.; Hanotin, C.; Golay, Alain

Published inExperimental and clinical endocrinology & diabetes, vol. 121, no. 01, p. 20-26

Publication date2012

Abstract

In obesity, a dysregulation of the endocannabinoid system has been shown. The endocannabinoid receptor blockage by rimonabant demonstrated interesting metabolic effects. However, the role of rimonabant in weight loss of patients with binge eating disorder has not been investigated. Thus, our aim was to evaluate the effects of rimonabant on body weight in obese patients with binge eating disorders.

Keywords

Endocannabinoid system, Rimonabant, Obesity, Binge eating disorder

UNIGE affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

UNIGE research groups

Education thérapeutique du patient, diabète et obésité (600)

Citation (ISO format)

PATAKY, Zoltan et al. Efficacy of rimonabant in obese patients with binge eating disorder. In: Experimental and clinical endocrinology & diabetes, 2012, vol. 121, n° 01, p. 20–26. doi: 10.1055/s-0032-1329957

Article (Published version)

Identifiers

PID : unige:32323
DOI : 10.1055/s-0032-1329957
PMID : 23147209

Journal ISSN0947-7349

643views

0downloads

Creation05/12/2013 10:05:00

First validation05/12/2013 10:05:00

Update14/03/2023 20:44:35

Status update14/03/2023 20:44:35

Last indexation30/10/2024 15:26:59

Archive ouverte UNIGE

Efficacy of rimonabant in obese patients with binge eating disorder

Technical informations